These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28617888)

  • 1. Position paper on treatment of hepatitis C in Romania, 2017. Part one.
    Gheorghe L; Sporea I; Iacob S; Şirli R; Trifan A; Dobru D; Diculescu M; Stanciu C; Pascu O; Acalovschi M; Brisc C; Cijevschi C; Gheorghe C; Spârchez Z; Rogoveanu I; Dumitrascu D
    J Gastrointestin Liver Dis; 2017 Jun; 26(2):171-181. PubMed ID: 28617888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two.
    Gheorghe L; Sporea I; Iacob S; Sirli R; Trifan A; Diculescu M; Stanciu C; Pascu O; Acalovschi M; Brisc C; Cijevschi C; Gheorghe C; Spârchez Z; Rogoveanu I; Dobru D; Dumitrascu DL
    J Gastrointestin Liver Dis; 2017 Sep; 26(3):309-317. PubMed ID: 28922445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of HCV Infection and Risk Factors in a Hospital- Based Population Screening, a First Step to the Micro-Elimination of HCV Infection in Medical Institutions from Romania - Results of the HepC ALERT Study.
    Gheorghe L; Iacob S; Csiki IE; Huiban L; Cojocaru M; Cojocariu C; Nemteanu R; Girleanu I; Sirli R; Singeap AM; Pop C; Dumitrascu DL; Vadan R; Iacob R; Diculescu M; Trifan A; Sporea I; Gheorghe C
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):587-593. PubMed ID: 33331354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Seroprevalence Study of Hepatitis B and C Virus Infections in a Hospitalized Population in Romania, an Opportunity for a Better National Prevention and Control Strategy.
    Popovici O; Molnar GB; Popovici F; Janţă D; Pistol A; Azoicăi D
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):25-32. PubMed ID: 27014751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatitis C infection among patients with renal failure.
    Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection management in 2012.
    Van Gulick JJ; Lamers MH; Drenth JP
    Panminerva Med; 2012 Mar; 54(1):1-9. PubMed ID: 22278112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
    AASLD-IDSA HCV Guidance Panel
    Clin Infect Dis; 2018 Oct; 67(10):1477-1492. PubMed ID: 30215672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral hepatitis C in 2014--the beginning of the end?
    Prelipcean CC; Gogălniceanu P; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):272-8. PubMed ID: 25076687
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
    Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to peginterferon plus ribavirin therapy for hepatitis C in Romania between 2002-2009.
    Gheorghe L; Pascu O; Ceausu E; Csiki IE; Iacob S; Caruntu F; Simionov I; Vadan R
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):161-7. PubMed ID: 20593049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-elimination of hepatitis C virus infection - the beginning of the end.
    Huiban L; Stanciu C; Sfarti C; Muzica C; Cuciureanu T; Zenovia S; Frunzuc G; Damian I; Trifan A
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):688. PubMed ID: 33331344
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis.
    Feng B; Eknoyan G; Guo ZS; Jadoul M; Rao HY; Zhang W; Wei L
    Nephrol Dial Transplant; 2012 Feb; 27(2):640-6. PubMed ID: 21558431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New hepatitis C therapies: the toolbox, strategies, and challenges.
    Pawlotsky JM
    Gastroenterology; 2014 May; 146(5):1176-92. PubMed ID: 24631495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.
    Degasperi E; Caprioli F; El Sherif O; Back D; Colombo M; Aghemo A
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1373-1383. PubMed ID: 27718758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus guidelines for the management of hepatitis C infection.
    Consensus Guidelines Committee for the Management of Hepatitis C Infection
    Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.
    Vespasiani-Gentilucci U; Galati G; Gallo P; De Vincentis A; Riva E; Picardi A
    World J Gastroenterol; 2015 Jun; 21(24):7412-26. PubMed ID: 26139987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
    Makara M; Horváth G; Gervain J; Pár A; Szalay F; Telegdy L; Tornai I; Ujhelyi E; Hunyady B
    Orv Hetil; 2012 Mar; 153(10):375-94. PubMed ID: 22370225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand.
    Vermunt J; Fraser M; Herbison P; Wiles A; Schlup M; Schultz M
    World J Gastroenterol; 2015 Sep; 21(35):10224-33. PubMed ID: 26401088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.